Pura Vida Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-50,000	Closed	-$4.94M	–	45
2024 Q3	$4.94M	Buy	+50,000	New	+$4.91M	3.22%	13
2021 Q2	–	Sell	-1,650,000	Closed	-$224M	–	278
2021 Q1	$224M	Buy	1,650,000 +480,900	+41%	+$72M	6.38%	4
2020 Q4	$165M	Buy	1,169,100 +166,200	+17%	+$21.3M	5.98%	4
2020 Q3	$112M	Buy	1,002,900 +670,900	+202%	+$75.2M	5.76%	3
2020 Q2	$37.2M	Sell	332,000 -288,000	-46%	-$28.4M	3.57%	5
2020 Q1	$48M	Buy	620,000 +192,000	+45%	+$17M	5.7%	3
2019 Q4	$40.7M	Buy	428,000 +278,000	+185%	+$24M	3.58%	4
2019 Q3	$11.4M	Buy	+150,000	New	+$12.5M	1.95%	19
2019 Q2	–	Sell	-50,000	Closed	-$4.53M	–	124
2019 Q1	$4.53M	Buy	+50,000	New	+$4.25M	0.64%	48
2018 Q4	–	Sell	-50,000	Closed	-$4.79M	–	111
2018 Q3	$4.79M	Sell	50,000 -50,000	-50%	-$4.85M	1.01%	30
2018 Q2	$9.52M	Buy	+100,000	New	+$9.19M	3.81%	4
2018 Q1	–	Sell	-87,500	Closed	-$7.43M	–	96
2017 Q4	$7.43M	Buy	87,500 +37,500	+75%	+$3.14M	3.11%	7
2017 Q3	$4.33M	Buy	+50,000	New	+$4.01M	1.27%	30
2016 Q1	–	Sell	-85,000	Closed	-$5.97M	–	99
2015 Q4	$5.97M	Buy	+85,000	New	+$5.8M	2.52%	12
2015 Q1	–	Sell	-56,100	Closed	-$3.49M	–	85
2014 Q4	$3.49M	Buy	+56,100	New	+$3.2M	1.28%	26